Skip to content

What level of firmness is required for compression therapy in lipedema?

What level of firmness is required for compression therapy in lipedema? - Compression in Lipedema

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00040739
Enrollment
20
Registered
2026-07-02
Start date
2026-07-03
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E88.20 E88.21 E88.22

Interventions

Group 1: This is a prospective, single-arm exploratory study. Twenty women with lipedema who are already receiving compression therapy will be switched to a flat-knit compression garment (CuraFlow®, B

Sponsors

Venenpraxis Wunstorf
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Women with lipedema who have been using compression therapy for at least one year, provided that their current compression garment is not the study product Willingness to wear the study product (two sets of compression garments) as the sole compression therapy for four weeks

Exclusion criteria

Exclusion criteria: Active malignancy Diabetic neuropathy Exudative skin disorders of the lower extremities or active infections Pregnancy (not because of any anticipated risk to the mother or the unborn child, but due to the potential influence of pregnancy on oedema formation) Severe comorbid conditions whose symptoms may substantially interfere with the assessment of lipedema-related pain (e.g. recent hip surgery or severe pain caused by lumbar spine disorders) Inability to provide informed consent Insufficient proficiency in the German language to understand study information and complete study questionnaires Participation in another clinical study within the previous four weeks

Design outcomes

Primary

MeasureTime frame
The primary endpoint is assessed using a study-specific questionnaire based on a 0–10 numerical rating scale. Participants' evaluations of their existing compression garment are compared with their evaluations of the study garment after four weeks of use.

Secondary

MeasureTime frame
Secondary endpoints include changes in pain intensity after four weeks, changes in diagnostic findings such as tenderness on palpation and the presence of concomitant lymphoedema, as well as patient compliance and adherence to compression therapy.

Countries

Germany

Contacts

Public ContactErika Mendoza

Venenpraxis Wunstorf

Erika.mendoza@t-online.de00-49-1732436531

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026